Switch to:
GuruFocus has detected 6 Warning Signs with Teva Pharmaceutical Industries Ltd $TEVA.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Cash Flow from Others
$2,032 Mil (TTM As of Dec. 2016)

Teva Pharmaceutical Industries Ltd's cash flow from others for the three months ended in Dec. 2016 was $1,495 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2016 was $2,032 Mil.


Definition

Teva Pharmaceutical Industries Ltd Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2016 was 276 (Mar. 2016 ) + 670 (Jun. 2016 ) + -409 (Sep. 2016 ) + 1495 (Dec. 2016 ) = $2,032 Mil.


Related Terms

Cash Flow from Operations


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Cash Flow from Others 831,9311021441121,1486904181,3162,032

Teva Pharmaceutical Industries Ltd Quarterly Data

Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16
Cash Flow from Others 161151179192792153276670-4091,495
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK